MovDisordV3, PascalFrancis, Corpus, bibRecord, 000F72

Validity of the Cornell Scale for Depression in Dementia in Parkinson's Disease with and without Cognitive Impairment

Identifieur interne : 000F72 ( PascalFrancis/Corpus ); précédent : 000F71; suivant : 000F73

Validity of the Cornell Scale for Depression in Dementia in Parkinson's Disease with and without Cognitive Impairment

Auteurs : James R. Williams ; Laura Marsh

Source :

Movement disorders [ 0885-3185 ] ; 2009.

RBID : Pascal:09-0136784

Descripteurs français

Pascal (Inist)
- Etat dépressif, Démence, Maladie de Parkinson, Trouble cognitif, Pathologie du système nerveux, Validité, Cognition, Echelle d'évaluation.

English descriptors

KwdEn :
- Cognition, Cognitive disorder, Dementia, Depression, Evaluation scale, Nervous system diseases, Parkinson disease, Validity.

Abstract

Valid tools are needed to assess depression across the spectrum of cognitive impairment in Parkinson's disease (PD). The validity of the Cornell scale for depression in dementia (CSDD) was tested in a PD sample with a range of cognitive impairment. Psychiatric diagnoses were established according to DSM-IV-TR. Receiver operating characteristic curves tested the discriminant validity of the CSDD compared to the clinical diagnoses of major and minor depression. The curve for symptomatic depression had an area under the curve of 0.82. For the cut-off score ≥ 6, sensitivity was 0.83 and specificity was 0.73; for the cut-off score ≥ 8, sensitivity was 0.75 and specificity was 0.82. There was no evidence for differential measurement with respect to cognitive impairment or any other demographic or clinical variables. This study suggests that the CSDD is a valid tool for identifying depressive disorders in patients with PD across a spectrum of cognitive impairment.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 24`
A06				`@2 3`
A08	`01`	`1`	`ENG`	`@1 Validity of the Cornell Scale for Depression in Dementia in Parkinson's Disease with and without Cognitive Impairment`
A11	`01`	`1`		`@1 WILLIAMS (James R.)`
A11	`02`	`1`		`@1 MARSH (Laura)`
A14	`01`			`@1 Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University School of Medicine @2 Baltimore, Maryland @3 USA @Z 1 aut.`
A14	`02`			`@1 Morris K. Udall Parkinson's Disease Research Center of Excellence, Johns Hopkins University School of Medicine @2 Baltimore, Maryland @3 USA @Z 1 aut. @Z 2 aut.`
A14	`03`			`@1 Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine @2 Baltimore, Maryland @3 USA @Z 2 aut.`
A14	`04`			`@1 Department of Neurology and Neurological Sciences Johns Hopkins University School of Medicine @2 Baltimore, Maryland @3 USA @Z 2 aut.`
A20				`@1 433-437`
A21				`@1 2009`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000186999840180`
A44				`@0 0000 @1 © 2009 INIST-CNRS. All rights reserved.`
A45				`@0 23 ref.`
A47	`01`	`1`		`@0 09-0136784`
A60				`@1 P @3 CC`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Valid tools are needed to assess depression across the spectrum of cognitive impairment in Parkinson's disease (PD). The validity of the Cornell scale for depression in dementia (CSDD) was tested in a PD sample with a range of cognitive impairment. Psychiatric diagnoses were established according to DSM-IV-TR. Receiver operating characteristic curves tested the discriminant validity of the CSDD compared to the clinical diagnoses of major and minor depression. The curve for symptomatic depression had an area under the curve of 0.82. For the cut-off score ≥ 6, sensitivity was 0.83 and specificity was 0.73; for the cut-off score ≥ 8, sensitivity was 0.75 and specificity was 0.82. There was no evidence for differential measurement with respect to cognitive impairment or any other demographic or clinical variables. This study suggests that the CSDD is a valid tool for identifying depressive disorders in patients with PD across a spectrum of cognitive impairment.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Etat dépressif @5 01`
C03	`01`	`X`	`ENG`	`@0 Depression @5 01`
C03	`01`	`X`	`SPA`	`@0 Estado depresivo @5 01`
C03	`02`	`X`	`FRE`	`@0 Démence @5 02`
C03	`02`	`X`	`ENG`	`@0 Dementia @5 02`
C03	`02`	`X`	`SPA`	`@0 Demencia @5 02`
C03	`03`	`X`	`FRE`	`@0 Maladie de Parkinson @2 NM @5 03`
C03	`03`	`X`	`ENG`	`@0 Parkinson disease @2 NM @5 03`
C03	`03`	`X`	`SPA`	`@0 Parkinson enfermedad @2 NM @5 03`
C03	`04`	`X`	`FRE`	`@0 Trouble cognitif @5 04`
C03	`04`	`X`	`ENG`	`@0 Cognitive disorder @5 04`
C03	`04`	`X`	`SPA`	`@0 Trastorno cognitivo @5 04`
C03	`05`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 05`
C03	`05`	`X`	`ENG`	`@0 Nervous system diseases @5 05`
C03	`05`	`X`	`SPA`	`@0 Sistema nervioso patología @5 05`
C03	`06`	`X`	`FRE`	`@0 Validité @5 09`
C03	`06`	`X`	`ENG`	`@0 Validity @5 09`
C03	`06`	`X`	`SPA`	`@0 Validez @5 09`
C03	`07`	`X`	`FRE`	`@0 Cognition @5 10`
C03	`07`	`X`	`ENG`	`@0 Cognition @5 10`
C03	`07`	`X`	`SPA`	`@0 Cognición @5 10`
C03	`08`	`X`	`FRE`	`@0 Echelle d'évaluation @5 11`
C03	`08`	`X`	`ENG`	`@0 Evaluation scale @5 11`
C03	`08`	`X`	`SPA`	`@0 Escala evaluación @5 11`
C07	`01`	`X`	`FRE`	`@0 Trouble de l'humeur @5 37`
C07	`01`	`X`	`ENG`	`@0 Mood disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Trastorno humor @5 37`
C07	`02`	`X`	`FRE`	`@0 Maladie dégénérative @5 38`
C07	`02`	`X`	`ENG`	`@0 Degenerative disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 38`
C07	`03`	`X`	`FRE`	`@0 Pathologie de l'encéphale @5 39`
C07	`03`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`03`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Syndrome extrapyramidal @5 40`
C07	`04`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`05`	`X`	`FRE`	`@0 Pathologie du système nerveux central @5 41`
C07	`05`	`X`	`ENG`	`@0 Central nervous system disease @5 41`
C07	`05`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 41`
N21				`@1 096`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 09-0136784 INIST
ET :	Validity of the Cornell Scale for Depression in Dementia in Parkinson's Disease with and without Cognitive Impairment
AU :	WILLIAMS (James R.); MARSH (Laura)
AF :	Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (1 aut.); Morris K. Udall Parkinson's Disease Research Center of Excellence, Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (1 aut., 2 aut.); Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (2 aut.); Department of Neurology and Neurological Sciences Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (2 aut.)
DT :	Publication en série; Courte communication, note brève; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2009; Vol. 24; No. 3; Pp. 433-437; Bibl. 23 ref.
LA :	Anglais
EA :	Valid tools are needed to assess depression across the spectrum of cognitive impairment in Parkinson's disease (PD). The validity of the Cornell scale for depression in dementia (CSDD) was tested in a PD sample with a range of cognitive impairment. Psychiatric diagnoses were established according to DSM-IV-TR. Receiver operating characteristic curves tested the discriminant validity of the CSDD compared to the clinical diagnoses of major and minor depression. The curve for symptomatic depression had an area under the curve of 0.82. For the cut-off score ≥ 6, sensitivity was 0.83 and specificity was 0.73; for the cut-off score ≥ 8, sensitivity was 0.75 and specificity was 0.82. There was no evidence for differential measurement with respect to cognitive impairment or any other demographic or clinical variables. This study suggests that the CSDD is a valid tool for identifying depressive disorders in patients with PD across a spectrum of cognitive impairment.
CC :	002B17; 002B17G
FD :	Etat dépressif; Démence; Maladie de Parkinson; Trouble cognitif; Pathologie du système nerveux; Validité; Cognition; Echelle d'évaluation
FG :	Trouble de l'humeur; Maladie dégénérative; Pathologie de l'encéphale; Syndrome extrapyramidal; Pathologie du système nerveux central
ED :	Depression; Dementia; Parkinson disease; Cognitive disorder; Nervous system diseases; Validity; Cognition; Evaluation scale
EG :	Mood disorder; Degenerative disease; Cerebral disorder; Extrapyramidal syndrome; Central nervous system disease
SD :	Estado depresivo; Demencia; Parkinson enfermedad; Trastorno cognitivo; Sistema nervioso patología; Validez; Cognición; Escala evaluación
LO :	INIST-20953.354000186999840180
ID :	09-0136784

Links to Exploration step

Pascal:09-0136784

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Validity of the Cornell Scale for Depression in Dementia in Parkinson's Disease with and without Cognitive Impairment</title>
<author><name sortKey="Williams, James R" sort="Williams, James R" uniqKey="Williams J" first="James R." last="Williams">James R. Williams</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Morris K. Udall Parkinson's Disease Research Center of Excellence, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Marsh, Laura" sort="Marsh, Laura" uniqKey="Marsh L" first="Laura" last="Marsh">Laura Marsh</name>
<affiliation><inist:fA14 i1="02"><s1>Morris K. Udall Parkinson's Disease Research Center of Excellence, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>Department of Neurology and Neurological Sciences Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0136784</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0136784 INIST</idno>
<idno type="RBID">Pascal:09-0136784</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000F72</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Validity of the Cornell Scale for Depression in Dementia in Parkinson's Disease with and without Cognitive Impairment</title>
<author><name sortKey="Williams, James R" sort="Williams, James R" uniqKey="Williams J" first="James R." last="Williams">James R. Williams</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Morris K. Udall Parkinson's Disease Research Center of Excellence, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Marsh, Laura" sort="Marsh, Laura" uniqKey="Marsh L" first="Laura" last="Marsh">Laura Marsh</name>
<affiliation><inist:fA14 i1="02"><s1>Morris K. Udall Parkinson's Disease Research Center of Excellence, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>Department of Neurology and Neurological Sciences Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cognition</term>
<term>Cognitive disorder</term>
<term>Dementia</term>
<term>Depression</term>
<term>Evaluation scale</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Validity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Etat dépressif</term>
<term>Démence</term>
<term>Maladie de Parkinson</term>
<term>Trouble cognitif</term>
<term>Pathologie du   système nerveux</term>
<term>Validité</term>
<term>Cognition</term>
<term>Echelle d'évaluation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Valid tools are needed to assess depression across the spectrum of cognitive impairment in Parkinson's disease (PD). The validity of the Cornell scale for depression in dementia (CSDD) was tested in a PD sample with a range of cognitive impairment. Psychiatric diagnoses were established according to DSM-IV-TR. Receiver operating characteristic curves tested the discriminant validity of the CSDD compared to the clinical diagnoses of major and minor depression. The curve for symptomatic depression had an area under the curve of 0.82. For the cut-off score ≥ 6, sensitivity was 0.83 and specificity was 0.73; for the cut-off score ≥ 8, sensitivity was 0.75 and specificity was 0.82. There was no evidence for differential measurement with respect to cognitive impairment or any other demographic or clinical variables. This study suggests that the CSDD is a valid tool for identifying depressive disorders in patients with PD across a spectrum of cognitive impairment.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>24</s2>
</fA05>
<fA06><s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Validity of the Cornell Scale for Depression in Dementia in Parkinson's Disease with and without Cognitive Impairment</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>WILLIAMS (James R.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>MARSH (Laura)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Morris K. Udall Parkinson's Disease Research Center of Excellence, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Neurology and Neurological Sciences Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA20><s1>433-437</s1>
</fA20>
<fA21><s1>2009</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000186999840180</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>23 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>09-0136784</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Valid tools are needed to assess depression across the spectrum of cognitive impairment in Parkinson's disease (PD). The validity of the Cornell scale for depression in dementia (CSDD) was tested in a PD sample with a range of cognitive impairment. Psychiatric diagnoses were established according to DSM-IV-TR. Receiver operating characteristic curves tested the discriminant validity of the CSDD compared to the clinical diagnoses of major and minor depression. The curve for symptomatic depression had an area under the curve of 0.82. For the cut-off score ≥ 6, sensitivity was 0.83 and specificity was 0.73; for the cut-off score ≥ 8, sensitivity was 0.75 and specificity was 0.82. There was no evidence for differential measurement with respect to cognitive impairment or any other demographic or clinical variables. This study suggests that the CSDD is a valid tool for identifying depressive disorders in patients with PD across a spectrum of cognitive impairment.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Etat dépressif</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Depression</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Estado depresivo</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Démence</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Dementia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Demencia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Trouble cognitif</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Cognitive disorder</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Trastorno cognitivo</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Validité</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Validity</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Validez</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Cognition</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Cognition</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Cognición</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Echelle d'évaluation</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Evaluation scale</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Escala evaluación</s0>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Trouble de l'humeur</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Mood disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Trastorno humor</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Pathologie du   système nerveux central</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>41</s5>
</fC07>
<fN21><s1>096</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 09-0136784 INIST</NO>
<ET>Validity of the Cornell Scale for Depression in Dementia in Parkinson's Disease with and without Cognitive Impairment</ET>
<AU>WILLIAMS (James R.); MARSH (Laura)</AU>
<AF>Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (1 aut.); Morris K. Udall Parkinson's Disease Research Center of Excellence, Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (1 aut., 2 aut.); Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (2 aut.); Department of Neurology and Neurological Sciences Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (2 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2009; Vol. 24; No. 3; Pp. 433-437; Bibl. 23 ref.</SO>
<LA>Anglais</LA>
<EA>Valid tools are needed to assess depression across the spectrum of cognitive impairment in Parkinson's disease (PD). The validity of the Cornell scale for depression in dementia (CSDD) was tested in a PD sample with a range of cognitive impairment. Psychiatric diagnoses were established according to DSM-IV-TR. Receiver operating characteristic curves tested the discriminant validity of the CSDD compared to the clinical diagnoses of major and minor depression. The curve for symptomatic depression had an area under the curve of 0.82. For the cut-off score ≥ 6, sensitivity was 0.83 and specificity was 0.73; for the cut-off score ≥ 8, sensitivity was 0.75 and specificity was 0.82. There was no evidence for differential measurement with respect to cognitive impairment or any other demographic or clinical variables. This study suggests that the CSDD is a valid tool for identifying depressive disorders in patients with PD across a spectrum of cognitive impairment.</EA>
<CC>002B17; 002B17G</CC>
<FD>Etat dépressif; Démence; Maladie de Parkinson; Trouble cognitif; Pathologie du   système nerveux; Validité; Cognition; Echelle d'évaluation</FD>
<FG>Trouble de l'humeur; Maladie dégénérative; Pathologie de l'encéphale; Syndrome extrapyramidal; Pathologie du   système nerveux central</FG>
<ED>Depression; Dementia; Parkinson disease; Cognitive disorder; Nervous system diseases; Validity; Cognition; Evaluation scale</ED>
<EG>Mood disorder; Degenerative disease; Cerebral disorder; Extrapyramidal syndrome; Central nervous system disease</EG>
<SD>Estado depresivo; Demencia; Parkinson enfermedad; Trastorno cognitivo; Sistema nervioso patología; Validez; Cognición; Escala evaluación</SD>
<LO>INIST-20953.354000186999840180</LO>
<ID>09-0136784</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F72 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000F72 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:09-0136784
   |texte=   Validity of the Cornell Scale for Depression in Dementia in Parkinson's Disease with and without Cognitive Impairment
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Validity of the Cornell Scale for Depression in Dementia in Parkinson's Disease with and without Cognitive Impairment

Validity of the Cornell Scale for Depression in Dementia in Parkinson's Disease with and without Cognitive Impairment

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri